Topics:

ACR: No Cancer Link Found with New Rheumatoid Arthritis Agents

ACR: No Cancer Link Found with New Rheumatoid Arthritis Agents

WASHINGTON, Nov. 15 -- There is no link of significance between major cancers and new biologic therapies for rheumatoid arthritis, FDA-mandated warnings not withstanding, a researcher said here.

"The bottom line is that, in general, these drugs are safe," said Fred Wolfe, M.D., of the National Databank for Rheumatic Disease (NDBRD) in Wichita, Kan., at the American College of Rheumatology meeting.

The FDA, prompted by reports of an increased risk of lymphoma seen in some clinical trials of the medications, added a warning on the labels of Remicade (inflixumab), Enbrel (etanercept), and Humira (adalimumab).

"In contradistinction," Dr. Wolfe said, "we found no overall increase in the rate of cancer associated with biologic therapies."

Pages

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.